A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults
2020
Annals of Blood
Preserved Fulltext
Group (IWG) as newly diagnosed ITP (acute; up until 3 months), persistent ITP (lasting 3-12 months, more prevalent in children), chronic ITP (lasting >12 months, more prevalent in adult patients) (2-4). This classification is important because patients with newly diagnosed and persistent ITP have significantly higher remission rates than patients with chronic ITP (2,5-8). Therefore, physicians usually recommend a more rigorous treatment plan for patients with chronic ITP, which is more
doi:10.21037/aob-20-87
fatcat:543iy7s7nbe2jovaxkgmtifuc4